Kumar Rajinder 4
4 · TITAN PHARMACEUTICALS INC · Filed Sep 19, 2017
Insider Transaction Report
Form 4
Kumar Rajinder
Director
Transactions
- Award
Option to Purchase Common Stock
2017-09-15+10,000→ 10,000 totalExercise: $1.50Exp: 2027-09-15→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option vests in 12 equal monthly installments commencing as of September 1, 2017.